A Belgian Randomized Trial in Hepatitis C Virus-Infected Patients with Persistently Normal Alanine Aminotransferase
Global Journal of Clinical Virology
Research Article
Persistently normal alanine aminotransferase (PNALT) is present in 30 to
40% of chronic hepatitis patients and it is generally accepted that
they have no liver damage. However, some studies suggest that there are
some degrees of mild to moderate histological liver damage. We evaluated
the fibrosis stage and the virological outcome in treated patients with
PNALT.
Scholarly Open access, Peertechz, Hyderabad
http://www.peertechz.com/Clinical-Virology/pdf/GJCV-1-101.pdf
Comments
Post a Comment